Techni Med, Inc. dba The Compounder
Letter data
- Company
- Techni Med, Inc. dba The Compounder
- Recipient
- Lawrence J. Frieders | Owner and Pharmacist in Charge | Techni Med, Inc. dba The Compounder | 340 Marshall Avenue | Unit 100 | Aurora | , | IL | 60506-5649 | United States
- Issue date
- 2020-05-05
- Posted date
- Not available
- FDA office
- Division of Pharmaceutical Quality Operations III
- Subject
- Not available
- Product
- Drugs
- CMS ID
- 493750
- Reference number
- CHI-10-16
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Techni Med, Inc. dba The Compounder
MARCS-CMS 493750 —
May 05, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
UPS Next Day
Reference #:
CHI-10-16
Product:
Drugs
Recipient:
Recipient Name
Lawrence J. Frieders
Recipient Title
Owner and Pharmacist in Charge
Techni Med, Inc. dba The Compounder
340 Marshall Avenue
Unit 100
Aurora
,
IL
60506-5649
United States
Issuing Office:
Division of Pharmaceutical Quality Operations III
United States
(313) 393-8100
Dear Mr. Frieders:
The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter (WL #CHI-10-16) dated July 29, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Nicholas F. Lyons
Compliance Director
Division of Pharmaceutical Quality Operations III
Content current as of:
05/12/2020
Regulated Product(s)
Drugs